A unique three-year project to bridge the divide between science and philosophy – which embedded early-career philosophers into some of Cambridge’s ground-breaking scientific research clusters – is the subject of a new film released today.
Researchers have shown how cholesterol – a molecule normally linked with cardiovascular diseases – may also play an important role in the onset and progression of Alzheimer’s disease.
Identification of brain region responsible for alleviating pain could lead to development of opioid alternatives27 Feb 2018
Researchers from the UK & Japan have identified how the brain’s natural painkilling system could be used as a possible alternative to opioids for the effective relief of chronic pain, which affects as many as one in three people at some point in their lives.
Researchers have found that excess levels of calcium in brain cells may lead to the formation of toxic clusters that are the hallmark of Parkinson’s disease.
A company in Silicon Valley claims to be developing a "whole brain interface” for communicating wirelessly with the world.
Christopher Markou from the Faculty of Law isn't overly keen...
Opinion: Robots and AI could soon have feelings, hopes and rights … we must prepare for the reckoning28 Feb 2017
Is artificial intelligence a benign and liberating influence on our lives – or should we fear an impending rise of the machines? And what rights should robots share with humans? Christopher Markou, a PhD candidate at the Faculty of Law, suggests an urgent need to start considering the answers.
It’s long been associated with anger and coarseness but profanity can have another, more positive connotation. Psychologists have learned that people who frequently curse are being more honest. Writing in the journal Social Psychological and Personality Science a team of researchers from the Netherlands, the UK, the USA and Hong Kong report that people who use profanity are less likely to be associated with lying and deception.
Researchers have identified the cause of chronic, and currently untreatable, pain in those with amputations and severe nerve damage, as well as a potential treatment which relies on engineering instead of drugs.
It's over a hundred years since the first case of Alzheimer’s disease was diagnosed. Since then we’ve learned a great deal about the protein ‘tangles’ and ‘plaques’ that cause the disease. How close are we to having effective treatments – and could we even prevent dementia from occurring in the first place?
A specific gene expression pattern maps out which parts of the brain are most vulnerable to Alzheimer’s disease, decades before symptoms appear, and helps define the molecular origins of the disease.